Invesco India Pharma and Healthcare Fund (Direct)
Invesco Mutual Fund · benchmark Nifty 500 TRI · 0.2 years old · AMFI code 154547
Not rated yet: a rating needs at least 3 years of history (1 year for index funds).
Returns against the index
| Period | Fund | Index (TRI) | Difference | Rank in category |
|---|---|---|---|---|
| 6 months | – | – | – | – |
| 1 year | – | – | – | – |
| 3 years (a year) | – | – | – | – |
| 5 years (a year) | – | – | – | – |
Growth option, point to point to 5 Nov 2026; periods over a year are annualised (CAGR). Index returns use the total-return index, which includes dividends.
Risk
Portfolio
Top 10 holdings, September 2026 portfolio.
Common questions
What is the NAV of Invesco India Pharma and Healthcare Fund (Direct plan)?
₹10.02 on 5 Nov 2026 (Growth option).
What is the expense ratio of Invesco India Pharma and Healthcare Fund (Direct)?
1.93% a year; the Regular plan's is 3.81%.
What does Invesco India Pharma and Healthcare Fund invest in?
Its largest holdings are Max Healthcare Institute Limited, Sun Pharmaceutical Industries Limited, Sai Life Sciences Limited, with 13 stocks in all (September 2026 portfolio).
Data as of 5 Nov 2026: NAVs from AMFI, index data from NSE Indices, portfolios from Invesco Mutual Fund's monthly disclosure. Updated every weekday. Read the scheme documents before investing.